137 related articles for article (PubMed ID: 28378423)
21. An efficient molecular genetic testing strategy for incontinentia pigmenti based on single-tube long fragment read sequencing.
Chen M; Tan MH; Liu J; Yang YM; Yu JL; He LJ; Huang YZ; Sun YX; Qian YQ; Yan K; Dong MY
NPJ Genom Med; 2024 May; 9(1):32. PubMed ID: 38811629
[TBL] [Abstract][Full Text] [Related]
22. Quantification of Genetic Heterogeneity Using Long-Read Targeted Individual DNA Molecule Sequencing.
Zhang Y; Chandrasekaran AP; Bi C; Li M
Curr Protoc; 2023 Sep; 3(9):e888. PubMed ID: 37729495
[TBL] [Abstract][Full Text] [Related]
23.
Steele C; You Z; Gitomer BY; Brosnahan GM; Abebe KZ; Braun WE; Chapman AB; Harris PC; Perrone RD; Steinman TI; Torres VE; Yu ASL; Chonchol M; Nowak KL
Kidney Int Rep; 2022 Jan; 7(1):117-120. PubMed ID: 35005320
[No Abstract] [Full Text] [Related]
24. Use of targeted sequence capture and high-throughput sequencing identifies a novel PKD1 mutation involved in adult polycystic kidney disease.
Sha YK; Sha YW; Mei LB; Huang XJ; Wang X; Lin SB; Li L; Li P
Gene; 2017 Nov; 634():1-4. PubMed ID: 28870863
[TBL] [Abstract][Full Text] [Related]
25. Bicaudal C mutation causes myc and TOR pathway up-regulation and polycystic kidney disease-like phenotypes in Drosophila.
Gamberi C; Hipfner DR; Trudel M; Lubell WD
PLoS Genet; 2017 Apr; 13(4):e1006694. PubMed ID: 28406902
[TBL] [Abstract][Full Text] [Related]
26. Defective glycolysis and the use of 2-deoxy-D-glucose in polycystic kidney disease: from animal models to humans.
Magistroni R; Boletta A
J Nephrol; 2017 Aug; 30(4):511-519. PubMed ID: 28390001
[TBL] [Abstract][Full Text] [Related]
27. Inflammation and Fibrosis in Polycystic Kidney Disease.
Song CJ; Zimmerman KA; Henke SJ; Yoder BK
Results Probl Cell Differ; 2017; 60():323-344. PubMed ID: 28409351
[TBL] [Abstract][Full Text] [Related]
28. HALC: High throughput algorithm for long read error correction.
Bao E; Lan L
BMC Bioinformatics; 2017 Apr; 18(1):204. PubMed ID: 28381259
[TBL] [Abstract][Full Text] [Related]
29. Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
Torres VE; Chapman AB; Devuyst O; Gansevoort RT; Perrone RD; Dandurand A; Ouyang J; Czerwiec FS; Blais JD;
Nephrol Dial Transplant; 2018 Mar; 33(3):477-489. PubMed ID: 28379536
[TBL] [Abstract][Full Text] [Related]
30. The mutation-free embryo for in vitro fertilization selected by MALBAC-PGD resulted in a healthy live birth from a family carrying PKD 1 mutation.
Li W; Ma Y; Yu S; Sun N; Wang L; Chen D; Yang G; Lu S; Li Y; Yang B; Mei C
J Assist Reprod Genet; 2017 Dec; 34(12):1653-1658. PubMed ID: 28825164
[TBL] [Abstract][Full Text] [Related]
31. Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study.
Girardat-Rotar L; Puhan MA; Braun J; Serra AL
J Nephrol; 2018 Feb; 31(1):87-94. PubMed ID: 28386880
[TBL] [Abstract][Full Text] [Related]
32. Ouabain promotes partial epithelial to mesenchymal transition (EMT) changes in human autosomal dominant polycystic kidney disease (ADPKD) cells.
Venugopal J; McDermott J; Sanchez G; Sharma M; Barbosa L; Reif GA; Wallace DP; Blanco G
Exp Cell Res; 2017 Jun; 355(2):142-152. PubMed ID: 28385574
[TBL] [Abstract][Full Text] [Related]
33. Validation of copy number variation analysis for next-generation sequencing diagnostics.
Ellingford JM; Campbell C; Barton S; Bhaskar S; Gupta S; Taylor RL; Sergouniotis PI; Horn B; Lamb JA; Michaelides M; Webster AR; Newman WG; Panda B; Ramsden SC; Black GC
Eur J Hum Genet; 2017 Jun; 25(6):719-724. PubMed ID: 28378820
[TBL] [Abstract][Full Text] [Related]
34. Mutational Screening of PKD1 and PKD2 Genes in Iranian Population Diagnosed with Autosomal Dominant Polycystic Kidney Disease.
Ranjzad F; Tara A; Basiri A; Aghdami N; Moghadasali R
Clin Lab; 2017 Jul; 63(7):1261-1267. PubMed ID: 28792715
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease.
Yao Q; Wu M; Zhou J; Zhou M; Chen D; Fu L; Bian R; Xing X; Sun L; Hu X; Li L; Dai B; Wüthrich RP; Ma Y; Mei CL
Kidney Blood Press Res; 2017; 42(1):156-164. PubMed ID: 28395294
[TBL] [Abstract][Full Text] [Related]
36. Hereditary polycystic kidney disease is characterized by lymphopenia across all stages of kidney dysfunction: an observational study.
Van Laecke S; Kerre T; Nagler EV; Maes B; Caluwe R; Schepers E; Glorieux G; Van Biesen W; Verbeke F
Nephrol Dial Transplant; 2018 Mar; 33(3):489-496. PubMed ID: 28387829
[TBL] [Abstract][Full Text] [Related]
37. Long-Read Sequencing Emerging in Medical Genetics.
Mantere T; Kersten S; Hoischen A
Front Genet; 2019; 10():426. PubMed ID: 31134132
[TBL] [Abstract][Full Text] [Related]
38. Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation.
Zacchia M; Blanco FDV; Trepiccione F; Blasio G; Torella A; Melluso A; Capolongo G; Pollastro RM; Piluso G; Di Iorio V; Simonelli F; Viggiano D; Perna A; Nigro V; Capasso G
J Nephrol; 2021 Dec; 34(6):1855-1874. PubMed ID: 33964006
[TBL] [Abstract][Full Text] [Related]
39. Clinical genetic diagnostics in Danish autosomal dominant polycystic kidney disease patients reveal possible founder variants.
Nielsen ML; Lildballe DL; Rasmussen M; Bojesen A; Birn H; Sunde L
Eur J Med Genet; 2021 Apr; 64(4):104183. PubMed ID: 33639313
[TBL] [Abstract][Full Text] [Related]
40. Human C-terminal CUBN variants associate with chronic proteinuria and normal renal function.
Bedin M; Boyer O; Servais A; Li Y; Villoing-Gaudé L; Tête MJ; Cambier A; Hogan J; Baudouin V; Krid S; Bensman A; Lammens F; Louillet F; Ranchin B; Vigneau C; Bouteau I; Isnard-Bagnis C; Mache CJ; Schäfer T; Pape L; Gödel M; Huber TB; Benz M; Klaus G; Hansen M; Latta K; Gribouval O; Morinière V; Tournant C; Grohmann M; Kuhn E; Wagner T; Bole-Feysot C; Jabot-Hanin F; Nitschké P; Ahluwalia TS; Köttgen A; Andersen CBF; Bergmann C; Antignac C; Simons M
J Clin Invest; 2020 Jan; 130(1):335-344. PubMed ID: 31613795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
